PDL BioPharma Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
PDL BioPharma (PDLI) Declares $0.05 Quarterly Dividend; 6.1% Yield
May 4, 2016 6:52 PM EDTPDL BioPharma (NASDAQ: PDLI) declared a quarterly dividend of $0.05 per share, or $0.2 annualized.
The dividend will be payable on June 13, 2016, to stockholders of record on June 6, 2016, with an ex-dividend date of June 2, 2016.
The annual yield on the dividend is 6.1... More
PDL BioPharma (PDLI) Tops Q1 EPS by 2c
May 4, 2016 6:51 PM EDTPDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $103.4 million versus the consensus estimate of $142.05 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
... More